ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
Study finds no link between mRNA COVID vaccines early in pregnancy and birth defects
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
Researchers Announce a phone book-sized surgical kit designed for the world’s most extreme environments
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
Japan declares a flu epidemic — what this means for other nations
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
New Human Liver Organoid Platform Predicts Immune-Mediated Drug Toxicity
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
Biotechnology | Diagnostics | Disease | FDA | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
New lab-grown human embryo model produces blood cells
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
Pig liver transplant into a living person edges it closer to the norm
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
Nobel Prize for Chemistry awarded to Susumu Kitagawa, Richard Robson, and Omar M. Yaghi
On Oct. 8, 2025, The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in…
Biotechnology | Clinical Research | Infectious Disease | Medical Device | Therapeutics | Vaccine | WHO
WHO launches the Global Clinical Trials Forum
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
Disease | Environmental | WHO
WHO Reports 1 in 5 adults still addicted to tobacco
On Oct. 6, 2025, the World Health Organization (WHO) reported world is smoking less, but the tobacco epidemic…
Bath scientists design peptide ‘switch’ that keeps Parkinson’s protein in its healthy form
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
On Oct. 6, 2026, The Nobel Assembly has awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E….
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
FDA Announces New ANDA Prioritization Pilot to Support U.S. Generic Drug Manufacturing and Testing
On Oct. 3, 2025, the U.S. Food and Drug Administration (FDA) announced a new pilot prioritization program for…
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…